Reynolds Cameron John
SEC CIK 1340610 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VNRX | VOLITIONRX LTD | Pres, CEO, Dir | 3.12M | $343.4K | — | 25 | 2022-04-07 | 2026-02-26 |
Most active insiders at VNRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reynolds Cameron John | Pres, CEO, Dir | $63.1K | — |
| 2 | Innes Guy Archibald | Dir | $49.0K | — |
| 3 | STILL TIMOTHY I | Dir | $24.5K | — |
| 4 | Rubin Ethel | Dir | — | — |
| 5 | Retter Andrew | Chief Medical Off | — | — |
| 6 | Batchelor Ann-Louise | Group CMO | — | — |
| 7 | Henshall Mickie | Dir | — | — |
| 8 | Plummer Nicholas | GC - Volition Diagnostics | — | — |
| 9 | Nguyen Kim | Dir | — | — |
| 10 | Forterre Gael | Chief Commercial Off | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-26 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +486.0K | 3.12M | +18% | $0 | |
| 2026-01-23 | 2026-01-22 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +74.7K | 2.63M | +3% | $0 | |
| 2025-11-17 | 2025-11-17 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $0.35 | +20.0K | 2.55M | +0.8% | +$7,000 | |
| D | 2025-10-15 | 2025-10-14 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $0.51 | +110.0K | 2.53M | +5% | +$56.1K |
| 2025-09-15 | 2025-09-12 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $0.66 | +15.0K | 2.62M | +0.6% | +$9,900 | |
| 2025-08-06 | 2025-08-05 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $0.64 | +78.1K | 2.61M | +3% | +$50.0K | |
| 2025-07-25 | 2025-07-24 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +200.0K | 2.53M | +9% | $0 | |
| 2025-06-16 | 2025-06-12 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $0.59 | +12.5K | 2.33M | +0.5% | +$7,375 | |
| 2025-05-19 | 2025-05-19 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $0.44 | +20.0K | 2.32M | +0.9% | +$8,800 | |
| 2025-03-27 | 2025-03-26 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $0.55 | +181.8K | 2.30M | +9% | +$100.0K | |
| 2024-12-10 | 2024-12-09 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $0.57 | +139.8K | 2.12M | +7% | +$79.7K | |
| 2024-09-04 | 2024-09-01 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +103.2K | 1.98M | +6% | $0 | |
| 2024-08-16 | 2024-08-15 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +29.5K | 1.87M | +2% | $0 | |
| 2024-06-04 | 2024-06-01 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +90.2K | 1.84M | +5% | $0 | |
| 2024-01-26 | 2024-01-24 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +50.1K | 1.75M | +3% | $0 | |
| 2023-12-11 | 2023-12-08 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $0.67 | +10.0K | 1.70M | +0.6% | +$6,700 | |
| 2023-10-20 | 2023-10-19 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +200.0K | 1.69M | +13% | $0 | |
| 2023-08-16 | 2023-08-16 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $1.22 | +10.0K | 1.49M | +0.7% | +$12.2K | |
| 2023-07-07 | 2023-07-05 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +40.0K | 1.48M | +3% | $0 | |
| 2023-01-13 | 2023-01-12 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +33.4K | 1.44M | +2% | $0 | |
| 2022-10-14 | 2022-10-13 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +15.6K | 1.41M | +1% | $0 | |
| 2022-10-06 | 2022-10-04 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +200.0K | 1.40M | +17% | $0 | |
| 2022-08-30 | 2022-08-30 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $1.61 | +3,500 | 1.20M | +0.3% | +$5,635 | |
| D | 2022-06-24 | 2022-06-23 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +32.3K | 1.19M | +3% | $0 |
| D | 2022-04-08 | 2022-04-07 | VNRX | VOLITIONRX LTD | Reynolds Cameron John | Pres, CEO, Dir | A - Grant | $0.00 | +17.4K | 1.16M | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations